A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
Public ClinicalTrials.gov record NCT03486392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Placebo-controlled and Open-label Active-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effects of JNJ-64565111 compared with placebo after 26 weeks of treatment on the percent change in body weight from baseline and to assess the safety and tolerability, in non-diabetic severely obese participants.
Study identification
- NCT ID
- NCT03486392
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 474 participants
Conditions and interventions
Conditions
Interventions
- JNJ-64565111 Dose Level 1 Drug
- JNJ-64565111 Dose Level 2 Drug
- JNJ-64565111 Dose Level 3 Drug
- Liraglutide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 26, 2018 (Actual)
- Primary completion
- Mar 8, 2019 (Actual)
- Completion
- Mar 8, 2019 (Actual)
- Last update posted
- Feb 5, 2020
2018 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Phoenix Medical Clinic | Phoenix | Arizona | 85020 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Care Partners Clinical Research | Jacksonville | Florida | 32277 | — |
| Advanced Clinical Research | Boise | Idaho | 83642 | — |
| Medisphere Medical Research Center, Llc | Evansville | Indiana | 47714 | — |
| L-Marc Research Center | Louisville | Kentucky | 40213 | — |
| Milford Emergency Associates, Inc. | Marlborough | Massachusetts | 01752 | — |
| Central New York Clinical Research | Manlius | New York | 13104 | — |
| Weill Cornell Medicine | New York | New York | 10065 | — |
| Rapid Medical Research | Cleveland | Ohio | 44122 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| Dallas Diabetes Research Center | Dallas | Texas | 75230 | — |
| Permian Research Foundation | Odessa | Texas | 79761 | — |
| Advanced Clinical Research | West Jordan | Utah | 84088 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
| Allegiance Reserach Specialists, LLC | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03486392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03486392 live on ClinicalTrials.gov.